Fate Therapeutics Inc. (FATE) Statistics & Valuation Metrics - Stocknear

Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.00
0.03 (3.01%)
At close: Sep 26, 2025, 3:59 PM
1.01
0.97%
After-hours: Sep 26, 2025, 07:17 PM EDT

Fate Therapeutics Statistics

Share Statistics

Fate Therapeutics has 115.33M shares outstanding. The number of shares has increased by 0.66% in one year.

115.33M
0.66%
0.03%
81.48%
100.8M
2,400
0.16%

Short Selling Information

The latest short interest is 9.65M, so 8.37% of the outstanding shares have been sold short.

9.65M
8.37%
9.55%
7.16

Valuation Ratios

The PE ratio is -1.01 and the forward PE ratio is -0.92. Fate Therapeutics's PEG ratio is 0.

-1.01
-0.92
13.76
19.9
0.59
-1.52
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Fate Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.58, with a Debt / Equity ratio of 0.27.

7.58
7.58
0.27
-0.48
-0.69
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$75.31K
$-1.03M
181
0.03
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -72.29% in the last 52 weeks. The beta is 2.22, so Fate Therapeutics's price volatility has been higher than the market average.

2.22
-72.29%
1.07
1.22
45.09
1,493,680

Income Statement

In the last 12 months, Fate Therapeutics had revenue of 13.63M and earned -186.26M in profits. Earnings per share was -1.64.

13.63M
13.63M
-210.28M
-186.26M
-176.58M
-195.54M
-1.64
Full Income Statement

Balance Sheet

The company has 36.06M in cash and 85.27M in debt, giving a net cash position of -49.21M.

36.06M
85.27M
-49.21M
-1.4B
371.63M
201.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -122.87M and capital expenditures -730K, giving a free cash flow of -123.6M.

-122.87M
-730K
-123.6M
-1.09
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -1542.63% and -1366.46%.

100%
-1542.63%
-1366.46%
-1366.46%
-1295.41%
-1542.63%
-906.79%

Dividends & Yields

FATE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for FATE is $3, which is 209.3% higher than the current price. The consensus rating is "Hold".

$3
209.3%
Hold
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-5.87
1